NoelleKLoConteMDFASCO(She/Her)

Oncology • Madison, WI

Gastrointestinal Cancer

Associate Professor of Medicine, University of Wisconsin School of Medicine and Public Health

Join to view full profile

Dr. LoConte is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. LoConte's full profile

Already have an account?

Office
600 Highland Ave
Madison, WI 53792
Phone+1 608-265-1700

Fax+1 608-262-1982

Summary

Associate Professor of Medicine with tenure

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Geriatric Medicine (Internal Medicine), 2005 - 2006
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2003 - 2005
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2001 - 2003
University of Wisconsin Hospitals and ClinicsInternship, Internal Medicine, 2000 - 2001
University of Illinois College of MedicineClass of 2000

Certifications & Licensure

OR State Medical License 2002 - Present
WI State Medical License 2003 - 2025
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Healthcare Hero 2021 Wisconsin Cancer Collaborative, 2021
Young Investigator Award American Society of Clinical Oncology
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Lithium for Low-Grade Neuroendocrine Tumors Start of enrollment: 2007 Jul 01
Completed
Phase 2
CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma Start of enrollment: 2008 Feb 01
Completed
Phase 1, Phase 2
Study of Panobinostat in Patients With Neuroendocrine Tumors Start of enrollment: 2010 May 01
Terminated
Phase 2
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors Start of enrollment: 2010 Jun 01
Completed
Phase 1
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma Start of enrollment: 2011 Aug 23
Completed
Phase 1
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer Start of enrollment: 2012 Oct 01
Completed
Phase 1, Phase 2
Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery Start of enrollment: 2013 Jan 15
Completed
Phase 1
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
Completed
Phase 2
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Start of enrollment: 2013 Sep 20
Active, not recruiting
Phase 2
Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting Start of enrollment: 2014 Feb 05
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

69 citations
A Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine Carcinoma
Tabraiz A. Mohammed, Kyle D. Holen, Renata Jaskula-Sztul, Daniel Mulkerin, Sam J. Lubner
The Oncologist. 2011-06-01
190 citations
Alcohol and Cancer: A Statement of the American Society of Clinical Oncology
Noelle K. LoConte, Abenaa M. Brewster, Judith S. Kaur, Janette K. Merrill, Anthony J. Alberg
Journal of Clinical Oncology. 2018-01-01
119 citations
Pancreatic Adenocarcinoma, Version 1.2019.
Margaret A Tempero, Mokenge P Malafa, E Gabriela Chiorean, Brian Czito, Courtney Scaife
Journal of the National Comprehensive Cancer Network. 2019-03-01

Lectures

Alcohol and Cancer: A Review of the ASCO Position Paper
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Authored Content

In the Words of My Mentor, 'The Best Cancer Is No Cancer.'June 2019
In the Words of My Mentor, 'The Best Cancer Is No Cancer.'June 2019
ASCO 2018: Dr. Noelle K. LoConte on Alcohol and Cancer: A Review of the ASCO Position PaperJune 2018
ASCO 2018: Dr. Noelle K. LoConte on Alcohol and Cancer: A Review of the ASCO Position PaperJune 2018
Join now to see all

Press Mentions

Partnership Successful at Reducing Lung Cancer Risk in Native PopulationSeptember 24th, 2024
Having an Alcoholic Drink or Two Per Day Is Not Healthier Than Abstaining, Study ShowsMarch 31st, 2023
Is Alcohol Bad for Your Health? Here's What the Science Actually SaysJanuary 24th, 2023
Join now to see all